Ibandronate Sodium (Apotex Corp.)
Welcome to the PulseAid listing for the Ibandronate Sodium drug offered from Apotex Corp.. This Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Apotex Corp. |
NON-PROPRIETARY NAME: | ibandronate sodium |
SUBSTANCE NAME: | IBANDRONATE SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-01-13 |
END MARKETING DATE: | 0000-00-00 |
Ibandronate Sodium HUMAN PRESCRIPTION DRUG Details:
Item Description | Ibandronate Sodium from Apotex Corp. |
LABELER NAME: | Apotex Corp. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3(mg/3mL) |
START MARKETING DATE: | 2016-01-13 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 60505-6097_b43342a6-c030-d812-8c28-ce3d70cc7e31 |
PRODUCT NDC: | 60505-6097 |
APPLICATION NUMBER: | ANDA204222 |
Other IBANDRONATE SODIUM Pharmaceutical Manufacturers / Labelers: